Faculty Earn State Grants for Cancer Research

A person in a lab.
September 21, 2022
The Cancer Prevention and Research Institute of Texas (CPRIT) has released its grant research funding awards for the upcoming year. All three awarded research projects at The University of Texas at Austin involve College of Pharmacy faculty.

Improving Health Outcomes for People Experiencing Homelessness is Focus of New Study

Five people holding cell phones and wearing masks.
April 30, 2021
Combining mobile health technology, or mHealth, and community outreach to improve the health outcomes of people experiencing homelessness is the target of a new study led by Division of Health Outcomes Associate Professor Leticia Moczygemba, Pharm.D., Ph.D., thanks to a five-year research grant from the U.S. Department of Health and Human Services Agency for Healthcare Research and Quality.

TxCORE Research Wins PhRMA Foundation Award

Three people smiling.
April 1, 2021
Three researchers from the College of Pharmacy won an award from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation. Leticia R. Moczygemba, Pharm.D., Ph.D., Carolyn M. Brown, Ph.D. and Michael Johnsrud, Ph.D., R.Ph. were awarded $5,000 from the PhRMA Foundation for their proposal to advance racial and ethnic representation in value assessments.

Inhaled Niclosamide a Potential Effective Antiviral to Treat COVID-19

An infrared image of nasal spray being administered.
September 29, 2020
Researchers in the lab of Dr. Hugh D.C. Smyth have released promising results of a new method to treat SARS-CoV-2, the coronavirus that causes COVID-19. The antiviral niclosamide, when incorporated with human lysozyme as a carrier molecule, shows potential as an effective COVID-19 treatment when delivered directly to the airways.

Live Subject Testing Shows Promising Delivery Method for COVID-19 Antiviral Treatment

A microscopic image.
September 23, 2020
Live subject testing results from the Williams Lab show that dry powder inhalation could be a potent and effective delivery method of the antiviral remdesivir to treat patients affected by COVID-19.

New Delivery Method Could Make Niclosamide an Effective Antiviral to Treat COVID-19

Two men in suits smiling.
April 6, 2020
A team of researchers in the college, led by Robert O. (Bill) Williams III and Hugh D. Smyth, is investigating varying methods of drug delivery to repurpose existing drugs in order to treat and prevent serious COVID-19 virus symptoms in patients.

Gore receives five-year NIH grant to research PCBs

gore large
April 2, 2019
Pharmacology and Toxicology Professor Andrea C. Gore, Ph.D. recently received an impressive five-year RO1 grant from the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes for Health (NIH), for research to determine how PCBs cause dysfunctions in reproductive physiology and behavior.

Vasquez collaborates on paper published in Nature

Karen Vasquez headshot
August 3, 2018
College of Pharmacy Professor Karen M. Vasquez, Ph.D. recently collaborated on a research paper exploring the mechanisms involved in DNA structure-induced genetic instability in human disease. “Mechanisms of genetic instability caused by (CGG)n repeats in an experimental mammalian system” recently published in Nature, and includes co-authors Artem V. Kononenko, Thomas Ebersole, and Sergei M. Mirkin from Tufts University.

Gonzales named AAAS fellow

Rueben Gonzales headshot
November 20, 2017
Professor Rueben Gonzales of the Department of Pharmacology and Toxicology was named a fellow of the American Association for the Advancement of Science (AAAS) for distinguished contributions to the field of alcohol research.

Williams named Inventor of the Year

Bill Williams Profile Pic
November 3, 2017
Bill Williams was named the 2017 Inventor of the Year by the university’s Office of Technology Commercialization.